. . . . . . . . . . . . . . . "kin(p(HGNC:ERBB2)) -> p(HGNC:CDK2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Our group and others have reported that anti-HER2 monoclonal antibodies exert inhibitory effects on HER2-overexpressing breast cancers through G1 cell cycle arrest associated with induction of p27Kip1 and reduction of CDK2." . . "Selventa" . . . . "2014-07-03T14:30:11.843+02:00"^^ . . .